checkAd
    Startseite > Aktien > Harrow Health > Nachrichten
    Harrow Health Aktie
    11,600
     
    USD
    +12,73 %
    +1,310 USD
    Letzter Kurs 11.05.24 Nasdaq
    11,600
     
    USD
    500 STK
    Geldkurs 10.05.24
    11,610
     
    USD
    2.000 STK
    Briefkurs 10.05.24
    ISIN: US4158581094 · WKN: A2PBJD · SYM: HROW · USA

    Neueste Nachrichten

    Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
    25.04.24 · Business Wire (engl.) · Harrow Health
    Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing
    02.04.24 · Business Wire (engl.) · Harrow Health
    Harrow Announces Fourth Quarter and Year-End 2023 Financial Results
    19.03.24 · Business Wire (engl.) · Harrow Health
    Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
    05.03.24 · Business Wire (engl.) · Harrow Health
    Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
    15.02.24 · Business Wire (engl.) · Harrow Health
    Harrow Announces New Appointments to its Board of Directors
    29.01.24 · Business Wire (engl.) · Harrow Health
    Harrow Announces Availability of VEVYE (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
    11.01.24 · Business Wire (engl.) · Harrow Health
    Melt Pharmaceuticals Provides Corporate Update
    03.01.24 · Business Wire (engl.) · Harrow Health
    Harrow Partners with Leading Healthcare Market Access Technology Platforms
    03.01.24 · Business Wire (engl.) · Harrow Health
    Harrow Completes Transfer of the TRIESENCE New Drug Application
    29.11.23 · Business Wire (engl.) · Harrow Health
    Harrow to Present at Two Investor Conferences in November
    20.11.23 · Business Wire (engl.) · Harrow Health
    Harrow Announces Third Quarter 2023 Financial Results
    13.11.23 · Business Wire (engl.) · Harrow Health